BridgeBio Oncology Therapeutics, Inc. (BBOT)
NASDAQ: BBOT · Real-Time Price · USD
12.31
+0.13 (1.07%)
Nov 28, 2025, 4:00 PM EST - Market closed

BBOT Balance Sheet

Millions USD. Fiscal year is Jan - Dec.
Fiscal Year
TTMFY 2024FY 2023
Period Ending
Sep '25 Dec '24 Dec '23
Cash & Equivalents
408.7430.850.25
Short-Term Investments
59.54124.78-
Cash & Short-Term Investments
468.29155.630.25
Cash Growth
187214.00%62152.40%-
Other Receivables
0.230.081.72
Receivables
0.230.081.72
Prepaid Expenses
7.52.981.96
Total Current Assets
476.01158.693.94
Property, Plant & Equipment
3.270.490.6
Other Long-Term Assets
5.525.121.41
Total Assets
484.79164.35.94
Accounts Payable
3.653.070.58
Accrued Expenses
30.8712.923.54
Other Current Liabilities
0.693.5912.66
Total Current Liabilities
35.7119.5816.78
Total Liabilities
38.0919.5816.78
Additional Paid-In Capital
764.4343.5432.61
Retained Earnings
-317.77-222.52-148.25
Comprehensive Income & Other
0.040.35-
Total Common Equity
446.7-178.64-115.64
Shareholders' Equity
446.7144.72-10.83
Total Liabilities & Equity
484.79164.35.94
Net Cash (Debt)
465.4155.630.25
Net Cash Growth
186059.20%62152.40%-
Net Cash Per Share
41.741072.392.00
Filing Date Shares Outstanding
79.990.320.12
Total Common Shares Outstanding
79.20.320.12
Working Capital
440.3139.11-12.84
Book Value Per Share
5.64-558.92-927.16
Tangible Book Value
446.7-178.64-115.64
Tangible Book Value Per Share
5.64-558.92-927.16
Updated Sep 30, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.